271 related articles for article (PubMed ID: 10916545)
21. [Superparamagnetic iron oxide in the differential diagnosis of focal hepatic lesions using a 0.5-tesla magnetic resonance apparatus].
Di Cesare E; Cariello G; Marchese F; Michelini O; Costanzi A; Catalucci A; Splendiani A; Masciocchi C
Radiol Med; 1998 Jun; 95(6):593-8. PubMed ID: 9717541
[TBL] [Abstract][Full Text] [Related]
22. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.
Ward J; Guthrie JA; Scott DJ; Atchley J; Wilson D; Davies MH; Wyatt JI; Robinson PJ
Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242
[TBL] [Abstract][Full Text] [Related]
24. Dynamic MRI of bladder cancer: evaluation of staging accuracy.
Tekes A; Kamel I; Imam K; Szarf G; Schoenberg M; Nasir K; Thompson R; Bluemke D
AJR Am J Roentgenol; 2005 Jan; 184(1):121-7. PubMed ID: 15615961
[TBL] [Abstract][Full Text] [Related]
25. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
[TBL] [Abstract][Full Text] [Related]
26. Bladder tumors: staging with gadolinium-enhanced oblique MR imaging.
Narumi Y; Kadota T; Inoue E; Kuriyama K; Fujita M; Hosomi N; Sawai Y; Kuroda M; Kotake T; Kuroda C
Radiology; 1993 Apr; 187(1):145-50. PubMed ID: 8451401
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging.
Barentsz JO; Berger-Hartog O; Witjes JA; Hulsbergen-van der Kaa C; Oosterhof GO; VanderLaak JA; Kondacki H; Ruijs SH
Radiology; 1998 Jun; 207(3):791-7. PubMed ID: 9609906
[TBL] [Abstract][Full Text] [Related]
28. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI.
Wu LM; Chen XX; Xu JR; Zhang XF; Suo ST; Yao QY; Fan Y; Hu J
Acad Radiol; 2013 Aug; 20(8):939-46. PubMed ID: 23746384
[TBL] [Abstract][Full Text] [Related]
29. Post-operative lumbar spine: comparative study of TSE T2 and turbo-FLAIR sequences vs contrast-enhanced SE T1.
Barrera MC; Alústiza JM; Gervás C; Recondo JA; Villanúa JA; Salvador E
Clin Radiol; 2001 Feb; 56(2):133-7. PubMed ID: 11222072
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
Yasumoto M; Shibuya H; Takeda M; Korenaga T
AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
[TBL] [Abstract][Full Text] [Related]
31. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
[TBL] [Abstract][Full Text] [Related]
32. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
Kim B; Semelka RC; Ascher SM; Chalpin DB; Carroll PR; Hricak H
Radiology; 1994 Oct; 193(1):239-45. PubMed ID: 8090898
[TBL] [Abstract][Full Text] [Related]
33. Normal bladder wall morphology in Gd-DTPA-enhanced clinical MR imaging using an endorectal surface coil and histological assessment of submucosal linear enhancement using [14C]Gd-DOTA autoradiography in an animal model.
Takeda K; Kawaguchi T; Shiraishi T; Kobayashi S; Hayashi N; Yanagawa M; Tochigi H; Sakuma H; Kawamura J; Nakagawa T
Eur J Radiol; 1998 Feb; 26(3):290-6. PubMed ID: 9587759
[TBL] [Abstract][Full Text] [Related]
34. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions.
Kumano S; Murakami T; Kim T; Hori M; Okada A; Sugiura T; Noguchi Y; Kawata S; Tomoda K; Nakamura H
AJR Am J Roentgenol; 2003 Nov; 181(5):1335-9. PubMed ID: 14573430
[TBL] [Abstract][Full Text] [Related]
35. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
Varallyay P; Nesbit G; Muldoon LL; Nixon RR; Delashaw J; Cohen JI; Petrillo A; Rink D; Neuwelt EA
AJNR Am J Neuroradiol; 2002 Apr; 23(4):510-9. PubMed ID: 11950637
[TBL] [Abstract][Full Text] [Related]
36. [Ultra-small superparamagnetic iron oxide particles: the signal behavior and relaxation times of the bone marrow after repeated i.v. application in the pig model at 1.5 tesla].
Cihal S; Maas R; Delling G; Klich S; Nielsen P; Lodemann KP; Bücheler E
Rofo; 1999 Aug; 171(2):149-54. PubMed ID: 10506890
[TBL] [Abstract][Full Text] [Related]
37. [A preparation technique for quantitative investigation of SPIO-containing solutions and SPIO-labelled cells by MRI].
Pintaske J; Helms G; Bantleon R; Kehlbach R; Wiskirchen J; Claussen CD; Schick F
Biomed Tech (Berl); 2005 Jun; 50(6):174-80. PubMed ID: 16003918
[TBL] [Abstract][Full Text] [Related]
38. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
Kuo YT; Chen CY; Liu GC; Wang YM
PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
[TBL] [Abstract][Full Text] [Related]
39. Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences.
Marcos HB; Semelka RC
J Magn Reson Imaging; 1999 Dec; 10(6):950-60. PubMed ID: 10581508
[TBL] [Abstract][Full Text] [Related]
40. Oral magnetic particles as a contrast agent for MR imaging of the abdomen. A phase III clinical trial.
Vlahos L; Gouliamos A; Kalovidouris A; Athanasopoulou A; Kotoulas G; Lygidakis N; Liaou A; Matsaidonis D; Papavasiliou C
Hepatogastroenterology; 1994 Feb; 41(1):82-5. PubMed ID: 8175124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
